Aortic Valve Stenosis Overview

Save information for later
Sign Up

Learn About Aortic Valve Stenosis

What is the definition of Aortic Valve Stenosis?
Aortic valve stenosis (AVS) is a condition characterized by narrowing of the heart's aortic valve opening. This narrowing prevents the valve from opening fully, which obstructs blood flow from the heart into the aorta, and onward to the rest of the body. AVS can range from mild to severe. Signs and symptoms typically develop when the narrowing of the opening is severe and may include chest pain (angina) or tightness; shortness of breath or fatigue (especially during exertion); feeling faint or fainting; heart palpitations; and heart murmur. Individuals with less severe congenital AVS (present at birth) may not develop symptoms until adulthood. Individuals with severe cases may faint without warning. AVS can have several causes including abnormal development before birth (such as having 1 or 2 valve leaflets instead of 3); calcium build-up on the valve in adulthood; and rheumatic fever.
What are the alternative names for Aortic Valve Stenosis?
  • Aortic valve stenosis
  • Aortic stenosis
  • Valvular aortic stenosis
Who are the top Aortic Valve Stenosis Local Doctors?
Isaac J. George
Elite in Aortic Valve Stenosis
Dr. Isaac J. George
Thoracic Surgery | General Surgery
Elite in Aortic Valve Stenosis
Dr. Isaac J. George
Thoracic Surgery | General Surgery

Trustees Of Columbia University In The City Of New York

622 W 168th St, 
New York, NY 
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Isaac George is a Thoracic Surgeon and a General Surgeon in New York, New York. Dr. George is rated as an Elite provider by MediFind in the treatment of Aortic Valve Stenosis. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Aortic Regurgitation, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Tanvir K. Bajwa
Elite in Aortic Valve Stenosis
Dr. Tanvir K. Bajwa
Interventional Cardiology
Elite in Aortic Valve Stenosis
Dr. Tanvir K. Bajwa
Interventional Cardiology

Aurora Cardiovascular Services

960 N 12th St, 
Milwaukee, WI 
414-219-7408
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Tanvir Bajwa is an Interventional Cardiologist in Milwaukee, Wisconsin. Dr. Bajwa is rated as an Elite provider by MediFind in the treatment of Aortic Valve Stenosis. His top areas of expertise are Aortic Valve Stenosis, Patent Foramen Ovale, Atrial Septal Defect (ASD), Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Aortic Valve Stenosis
Dr. Guilherme F. Attizzani
Cardiology
Elite in Aortic Valve Stenosis
Dr. Guilherme F. Attizzani
Cardiology

University Hospitals Medical Group Inc

11100 Euclid Ave, 
Cleveland, OH 
Languages Spoken:
English, Italian, Portuguese, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Guilherme Attizzani is a Cardiologist in Cleveland, Ohio. Dr. Attizzani is rated as an Elite provider by MediFind in the treatment of Aortic Valve Stenosis. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Coronary Heart Disease, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement. Dr. Attizzani is currently accepting new patients.

View All Doctors
What are the latest Aortic Valve Stenosis Clinical Trials?
The Utilization of Single Versus Double Perclose Devices for Transfemoral Aortic Valve Replacement Access Site Closure: A Prospective, Multicenter, Randomized Controlled Trial
The Utilization of Single Versus Double Perclose Devices for Transfemoral Aortic Valve Replacement Access Site Closure: A Prospective, Multicenter, Randomized Controlled Trial
Enrollment Status: Recruiting
Publish Date: October 14, 2025
Intervention Type: Device
Study Phase: Not Applicable

Summary: Transcatheter aortic valve replacement (TAVR) has become widely recognized as a minimally invasive approach for aortic valve replacement in patients with severe aortic stenosis. It has been proven to be a safe and effective option for patients who are at low, intermediate, and prohibitive risk for surgical valve replacement. One of the critical components of procedural success in a transfemoral ap...

Match to trials
Find the right clinical trials for you in under a minute
Get started
The PROGRESS Trial: A Prospective, Randomized, Controlled Trial to Assess the Management of Moderate Aortic Stenosis by Clinical Surveillance or Transcatheter Aortic Valve Replacement
The PROGRESS Trial: A Prospective, Randomized, Controlled Trial to Assess the Management of Moderate Aortic Stenosis by Clinical Surveillance or Transcatheter Aortic Valve Replacement
Enrollment Status: Recruiting
Publish Date: October 14, 2025
Intervention Type: Device
Study Phase: Not Applicable

Summary: This study objective is to establish the safety and effectiveness of the Edwards SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve systems in subjects with moderate, calcific aortic stenosis. Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center